title: Refractory highly disfiguring lupus pernio: a dramatic and prolonged response to infliximab.
authors.affiliation: Service of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Blanco
authors.affiliation: Service of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
authors.forename: Miguel A
authors.initials: MA
authors.lastname: González-Gay
authors.affiliation: Service of Dermatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain. marcosg@aedv.es.
authors.forename: Marcos A
authors.initials: MA
authors.lastname: González-López
authors.affiliation: Service of Dermatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
authors.forename: Héctor
authors.initials: H
authors.lastname: Fernández-Llaca
authors.affiliation: Department of Pathology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
authors.forename: M Carmen
authors.initials: MC
authors.lastname: González-Vela
mesh_terms: D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009668:Nose Diseases / Q000188:drug therapy*; D012507:Sarcoidosis / Q000188:drug therapy*; D012871:Skin Diseases / Q000188:drug therapy*
chemical_list: D003879:Dermatologic Agents; D000069285:Infliximab; D008727:Methotrexate